Sumitomo Dainippon Pharma Annual Report 2017
102/102

Corporate DataNameSumitomo Dainippon Pharma Co., Ltd.EstablishmentMay 14, 1897Date of MergerOctober 1, 2005Osaka Head Ofce6-8 Doshomachi 2-chome, Chuo-ku, Osaka 541-0045, JapanTEL: +81-6-6203-5321 FAX: +81-6-6202-6028Tokyo Head Ofce13-1, Kyobashi 1-chome, Chuo-ku,Tokyo 104-8356, JapanTEL: +81-3-5159-2500 FAX: +81-3-5159-2945Capital¥22.4 billionTotal Number ofShares Issued397,900,154Ordinary General Meeting of ShareholdersJuneAdministrator of Shareholders’ RegisterSumitomo Mitsui Trust Bank, LimitedAs of April 1, 2017Stock Exchange ListingTokyo Stock ExchangeIndependent PublicAccountantsKPMG AZSA LLCFiscal Year-endMarch 31Securities Code4506Sumitomo Mitsui Banking CorporationSumitomo Mitsui Trust Bank, LimitedThe Bank of Tokyo-Mitsubishi UFJ, Ltd.Main BanksOsaka Head Ofce (Osaka),Tokyo Head Ofce (Tokyo),15 Branches,4 Plants (Mie, Osaka, Ehime, Oita),2 Research Laboratories (Osaka),2 Distribution Centers (Saitama, Hyogo)Key FacilitiesDSP Gokyo Food & Chemical Co., Ltd.DS Pharma Animal Health Co., Ltd.DS Pharma Biomedical Co., Ltd.Sunovion Pharmaceuticals Inc. (U.S.)Boston Biomedical, Inc. (U.S.)Tolero Pharmaceuticals, Inc. (U.S.)Sumitomo Pharmaceuticals (Suzhou) Co., Ltd. (China)MajorConsolidatedSubsidiariesLead Managers(Main) Daiwa Securities Co., Ltd.;(Sub) SMBC Nikko Securities Inc.,Nomura Securities Co., Ltd.Issued on September, 2017IR Sitehttp://www.ds-pharma.com/ir/CSR Sitehttp://www.ds-pharma.com/csr/

元のページ  ../index.html#102

このブックを見る